Information Provided By: 
Fly News Breaks for June 15, 2015
BMRN
Jun 15, 2015 | 08:00 EDT
After speaking with specialists, Leerink continues to see a positive risk/reward for BioMarin into the BMN-111 for dwarfism data by the end of Q2. The company's goal of at least a 50% improvement in height velocity translates into a "relatively small" addition in stature of just 2 centimeters a year, the firm points out. It reiterates an Outperform rating on BioMarin with a $136 price target.
News For BMRN From the Last 2 Days
There are no results for your query BMRN
